Home > Publications > Medical Specialty > Internal Medicine > Respiratory > Respiratory > Respiratory Research Review Issue 127
Respiratory Research Review Issue 127

Respiratory Research Review Issue 127

In this issue:

Nucleoside-modified mRNA influenza vaccine
Adjunctive glucocorticoids for CAP
Durvalumab-carboplatin-etoposide for treatment-naive extensive-stage SCLC with poor performance status
Dupilumab vs. omalizumab for chronic rhinosinusitis with nasal polyps and coexisting asthma
An AIR algorithm approach for managing adult asthma
Azelastine nasal spray prevents SARS-COV-2 infection
Patients’ perspectives on uncontrolled moderate-to-severe asthma
Chewable pleuran-based supplement decreases respiratory tract infections in children
Nocturnal oxygen therapy for CSA in patients with HF
Ultraprocessed food consumption increases lung cancer risk

You need to be logged in to access this content.

Peter-Wark

Expert contributor

Professor Peter Wark

Prof Peter Wark is a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle, Australia and a conjoint Professor with the University of Newcastle. In addition, he is a senior investigator with the Priority Research Centre for Healthy Lungs and the Vaccines Immunology Viruses and Asthma research group at the Hunter […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.